[EN] USE OF A PEPTIDE FOR THE TREATMENT OF EPIDERM<br/>[FR] UTILISATION D'UN PEPTIDE POUR LE TRAITEMENT DE L'ÉPIDERME
申请人:SEDERMA SA
公开号:WO2019193113A1
公开(公告)日:2019-10-10
The peptide has the general Formula X-(Xaa)nK*TFK*-(Xaa)m-Z. It helps preserve or improve the condition of the epidermis. In the Formula, K* is selected from lysine K, ornithine, diaminobutyric acid or diaminopropionic acid, or a hydroxyl derivative; (Xaa)n and (Xaa)m independently of one another correspond to a sequence of n or m amino acids Xaa independently selected from among Gly, Ala, Pro, Val, Leu, Ile and Phe, with n and m integers which may be equal or different from 0 to 5; at the N-terminus X selected from H, -CO-R1, -SO2-R1 or a biotinoyl group; at the C-terminus Z selected from OH, OR1, NH2, NHR1 or NR1R2; and R1 and R2 being, independently of one another, selected from an alkyl, aryl, aralkyl, alkylaryl, alkoxy, saccharide and aryloxy group, which may be linear, branched, cyclic, polycyclic, unsaturated, hydroxylated, carbonylated, phosphorylated and/or sulfurated, said group having from 1 to 24 carbon atoms and may possess in its backbone an O, S and/or N heteroatom. A preferred peptide is the Pal-KTFK.